Aug 15, 2016, 08:24 AM by Michael Croft

LONDON, UNITED KINGDOM - Aug 15, 2016 - Titian Software (www.titian.co.uk), has announced that deployment of its Mosaic sample management software has resulted in simplified workflows and boosted productivity at Esteve's Compound Management Unit in Barcelona, after replacing their previous system

Aug 11, 2016, 10:05 AM by Michael Croft

Nature News | The surge of activity in recent years around CRISPR-Cas9 gene editing has also led to a flurry of modified CRISPR systems, or new systems entirely, which are starting to solve problems like delivering enzymes into cells, making specific changes to the DNA sequence, and editing RNA as well as DNA.

Aug 10, 2016, 13:28 PM by Michael Croft

BOSTON & LONDON - Aug 10, 2016 - IDBS and Cancer Research Technology (CRT), the commercialization arm of Cancer Research UK, have collaborated to streamline plate correction in high throughput screening (HTS)

Aug 10, 2016, 13:18 PM by Michael Croft

Computerworld | Intel is buying Nervana Systems, a deep learning startup based out of California. The deal speaks volumes about Intel's hopes for the future and where the company is going.

Aug 10, 2016, 09:50 AM by Michael Croft

Bio-IT World | As the Genome Analysis Toolkit, developed at the Broad Institute, continues to serve as the standby for parsing raw genomic data in public projects and major institutions, members of the Broad speak to Bio-IT World about forthcoming updates in GATK4 and new ventures incorporating the toolkit.

Aug 10, 2016, 09:12 AM by Michael Croft

PRINCETON, NJ - Aug 10, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of Phoenix 7

Aug 9, 2016, 09:30 AM by Michael Croft

Fast Company | The school will adopt the Google Genomics cloud platform to improve how it treats patients with cancer, as well as to diagnose children with mysterious, rare diseases.

Aug 8, 2016, 23:59 PM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Aug 8, 2016 - BOC Sciences officially announced that a new category of inhibitors-immune checkpoint inhibitors will began to be provided in system

Aug 8, 2016, 09:20 AM by Michael Croft

Bio-IT World | Software company Repositive aims to make PDX mice, crucial animal models for studying human-like cancers, searchable across vendors by indexing hundreds of different repositories in one platform.

Aug 5, 2016, 12:58 PM by Michael Croft

BAR HARBOR, ME - Aug 5, 2016 - Many lower organisms retain the miraculous ability to regenerate form and function of almost any tissue after injury

Aug 4, 2016, 09:23 AM by Michael Croft

The Seattle Times | Cray CEO Peter Ungaro considers the slowdown in the supercomputer market as "temporary."

Aug 3, 2016, 16:06 PM by Michael Croft

Forbes | Biotech and pharmaceutical industry professionals are busy people like everyone else. But they still find time to read books, especially when schedules slow down a tad during summer. So what are biotech professionals reading, and recommending, these days?

Aug 3, 2016, 12:13 PM by Michael Croft

KANSAS CITY, KS, UNITED STATES - Aug 3, 2016 - Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services

Aug 3, 2016, 10:45 AM by Michael Croft

Bio-IT World Briefs | Editas Medicine and Massachusetts General Hospital (MGH) announced an exclusive licensing agreement this morning, under which Editas can access intellectual property and technology related to high-fidelity Cas9 nucleases and Cas9 PAM variants that will enable the company to address an expanded range of genetically-defined diseases with the potential for enhanced specificity.

Aug 3, 2016, 09:33 AM by Michael Croft

Nature News & Comment | Daniel Himmelstein built a free online network to meld data from 28 public sources on links between drugs, genes, and diseases. Then he spent months chasing legal permission to republish the online data sets.

Aug 3, 2016, 09:32 AM by Michael Croft

PITTSBURGH, PA - Aug 3, 2016 - Curable, a non-profit research accelerator that applies engineering approaches to medicine to develop solutions for rare diseases, today announced that its Chief Executive Officer Lisa Boyette, MD, PhD, has been named a 2016 PharmaVOICE 100 honoree

Aug 2, 2016, 16:00 PM by Michael Croft

WSJ | Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and Allergan PLC, raising the possibility of another huge deal in the health-care industry.

Aug 2, 2016, 10:13 AM by Michael Croft

MUNICH, GERMANY - Aug 2, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of its Clinical Development Offering, making the company the premier provider of comprehensive tissue-based services from discovery to commercialization

Aug 2, 2016, 09:02 AM by Michael Croft

The New York Times | After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.

Aug 1, 2016, 22:21 PM by Michael Croft

STAT | Glaxo and Verily Life Sciences will invest $715 million in Galvani Bioelectronics and hope to win approval for their implantable devices in several years.